Siam Bioscience Co, the local biotechnology firm contracted to manufacture the AstraZeneca Covid-19 vaccine in Thailand, said it is confident that it will be able to deliver the vaccines on time once they have passed the required checks.
The company is in the process of sending samples of the vaccines it produced to several laboratories in Europe and the United States for quality inspection.
Once the samples are approved by the labs, they will be sent to AstraZeneca, which will then register the vaccine with the Thai Food and Drug Administration, so it can be mass-produced and used domestically, the company said.
After getting FDA’s approval, Siam Bioscience will ramp up the production of the vaccines.
Before the doses are delivered to the government in July as planned, they will be sent to AstraZeneca, who will carry out final quality and safety inspections, it…
